New technology of complex encapsulations and precision morphologies may be set to revolutionise pharmaceutical, cosmetic, and food products
Bio 2004 sees the launch of a unique technology for the fully scalable manufacture of micro- and nanoparticles.
Q Chip, a start-up company based in Cardiff, UK, says it can achieve complex encapsulations and precision morphologies in particles at <1% size variation, with exciting applications in the development of novel 'smart therapeutics'.
Q Chip's unique microfluidic system exploits the hydrophobic properties of polymer-based substrates, enabling the large-scale precision manufacture of high value microparticles, which would not be possible if performed in conventional large vessels. Through precise particle engineering, Q Chip can extend patent life, increase shelf life and open up new delivery methods such as inhaled versions of drugs that are currently injected - eg insulin therapy.
"It is no exaggeration to say that our technology can have a major impact on a company's business, and with potential applications in the biopharma, food and cosmetic industries the opportunities are far-ranging" said Jo Daniels, Q Chip's business development director. "For example particle size control is extremely important for pulmonary delivered therapeutics.
"Q Chip's technology produces particles in a very narrow size range (less than 1%) and for the first time offers a micronisation process capable of producing 2um protein particles - this gives a real indication of the power and possibilities of the technology".
The technology can be applied across numerous disciplines and industry sectors and, in the first instance, Q Chip is concentrating on applying the technology to polymers (medical devices), bioencapsulates (functional foods, cosmetics) and proteins (pharmaceutical).
Dr Daniels continued "We have already received interest from a number of multinational companies and we are actively seeking further partnering opportunities".
